FDA approves new ALS drug tested in clinical trial at UF
AMX0035 was tested at UF, Mass General and partnering sites and then approved by the FDA to treat ALS.
Posts tagged as
CENTAUR Trial
Researchers report experimental drug may prolong survival in ALS patients
Trial drug combination shows potential to prolong survival of ALS patients by more than six months.
New trial drug combination shows promise for slowing progression of ALS
UF was the No. 2 enroller of patients for multisite ALS trial.